使用不同交叉连接剂修改人类胚胎膜,作为再生医学有前途的工具
Joanna Skopinska-Wisniewska1, Marlena Michalak1, Jakub Tworkiewicz2
1Department of Chemistry of Biomaterials and Cosmetics, Nicolaus Copernicus University, Gagarina 7 Street, 87-100 Torun, Poland.
Materials (Basel, Switzerland)
|October 28, 2023
概括
这项研究通过交叉连接增强人胎膜 (hAM) 用于组织工程,提高其机械强度和稳定性,以便更好地临床使用.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 再生医学是一种再生医学.
背景情况:
- 人类羊水膜 (hAM) 是一个有价值的生物材料用于组织修复,因为它的再生特性.
- hAM的临床应用受到变化的刚性和快速降解的限制.
- 需要标准化的制备方法来确保一致的hAM性能.
研究的目的:
- 改善hAM的机械性能和稳定性,以提高临床效用.
- 研究各种蛋白质交叉链接剂对hAM特征的影响.
- 建立一种更可复制和标准化的hAM制备方法.
主要方法:
- 使用交叉链接剂修改了hAM样本:EDC/NHS,PEG-二甲基,PEG-NHS,二甲基粉和酸.
- 鉴定包括红外光谱学,热分析,机械测试,酶降解和细胞毒性测试.
- 评估了机械强度,延长,热稳定性和降解阻力的变化.
主要成果:
- 与PEG-二甲基,PEG-NHS,二甲基粉和酸的交叉链接显著增加了hAM的机械强度和破裂时的延伸.
- EDC/NHS交叉链接导致材料变硬和收缩.
- 修改后的hAM表现出增强的热稳定性和对酶降解的抗性.
- 细胞毒性测试证实了改性生物材料的安全性.
结论:
- 蛋白质交叉链接有效地增强了hAM的机械性能和稳定性.
- 特定的交叉连接剂为标准化用于临床应用的hAM准备提供了有希望的策略.
- 这项研究为开发更强大,更可靠的基于hAM的疗法提供了基础.
相关概念视频
Crossing Over
Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


